ArticleJTCVS techniques2025
Novel, noninvasive, extended reality-aided pulmonary tumor marking method for sublobar resection in minimally invasive surgery.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tumour Localisation Technologies in Colorectal Cancer Surgery: A Scoping Review of Marking and Detection Methods.Diagnostics (Basel, Switzerland) · 2026Review
- Preoperative localization of pulmonary nodules near the fissures: electromagnetic navigation bronchoscopy vs. hook-wire percutaneous localization.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: We developed a novel, noninvasive, extended reality-aided marking procedure for tumor localization and aimed to evaluate its feasibility and safety for sublobar resection in minimally invasive surgery. Methods: We prospectively evaluated the concordance rate between extended reality-aided marking and actual tumor localization for 20 patients who underwent sublobar resection, including wedge resection and segmentectomy. During sublobar resection, the augmented reality image of the 3-dimensional pulmonary anatomy and the tumor were overlaid onto the thoracoscopic monitor. This allowed the surgeons to observe the tumor location with the head-mounted mixed reality display during the surgery. Marking concordance was defined as the difference of 10 mm or less between the distances from the actual tumor margin and the identified marking point on the extended reality to the margin. Results: We enrolled 11 patients who underwent wedge resection and 9 patients who underwent segmentectomy. For each case, the pulmonary anatomy and tumor were successfully overlaid onto the operative image. The median computed tomography tumor size was 13.5 mm (interquartile range, 10.7-21.7 mm). The extended reality-aided marking method accurately delineated 90% of cases (18 of 20). The median distance from the actual surgical margin was 18 mm (interquartile range, 11-23.5 mm). The median duration of surgery was 117 (interquartile range, 64-147) minutes, and the perioperative courses were uneventful for all cases except for paroxysmal atrial fibrillation in 1 patient. Conclusions: Our novel, noninvasive, extended reality-based marking method is safe and feasible for identifying tumor locations during sublobar resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.